FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > New indication for PEA phase 2 coming soon

<< Previous

Bullboard Posts

Next >>

Comment by DavidRosenbergon Nov 09, 2021 12:48pm

27 Views

Post# 34105421

RE:RE:RE:RE:RE:New indication for PEA phase 2 coming soon

DavidRosenberg wrote:

Mil_Man54 wrote: Oh right the paid PR video where th interviewer is provided the quesitons to ask the CEO....we have seen these before and you have been the interviewer yourself a few times....these videos have never been a reliable source of information...promises made ...promises broken would be the most apt descriptor of the videos...strictly for PR hype.

DavidRosenberg wrote:

Mil_Man54 wrote: Where did you source this information from?.....

DavidRosenberg wrote: New indications for PEA drug molecule coming soon for FSD Pharma phase 2

FSD Pharma; Agreement Signed With Covar Pharmaceuticals to Support the Development of Lucid PSYCH - YouTube

In that latest video Anthony Durkacz mentioned they will be making an annoucement shortly and that they have two potential indications for phase 2 but wil be choosing one and annoying their decision shortly for phase 2 for PEA !!!!!!!!

You are completely 10000% wrong because Anthony is leading the company now. He has alot of skin in the game. PR videos are ways that EVERY company does updates to shareholders and markets and analysts this is needed.

So please spare me that nonsense that you just described, Spoken like a true shortseller basher.

So you are saying updates from the company going forward are not true?

I guess time will tell if they are able too achieve IND's in 2022 for their 2 new drugs

and i guess time will tell if they submit new INDICATION for PEA for phase 2 trials ;)

<< Previous

Bullboard Posts

Next >>

Yukon agency detects cyanide near Victoria Gold's Eagle mine